FDA Classifies Temporarily-Placed Urethral Opening System for Benign Prostatic Hyperplasia

Summary

The FDA has classified the device into Class II (special controls) to ensure its safety and effectiveness, aiming to enhance patients' access to innovative devices while reducing regulatory burdens.